ATC Group: A03FA08 Cinitapride

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A03FA08 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A03 Drugs for functional gastrointestinal disorders
3 A03F Propulsives
4 A03FA Propulsives
5 A03FA08

Active ingredients in A03FA08

Active Ingredient Description
Cinitapride

Cinitapride is an agonist of 5-HT4 and 5-HT1 receptors and antagonist of 5-HT2 receptors. Cinitapride is marketed worldwide for the treatment of gastrointestinal disorders related to motility such as indigestion or functional or non-ulcer dyspepsia, gastroesophageal reflux diseases, delay in gastric emptying and vomiting.

Medicines in this ATC group

Ecuador (EC)

Mexico (MX)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.